The store will not work correctly when cookies are disabled.
Methyl-[2-(3-phenyl-quinolin-2-ylsulfanyl)-ethyl]-amine hydrochloride
ID: ALA544293
PubChem CID: 13200208
Max Phase: Preclinical
Molecular Formula: C18H19ClN2S
Molecular Weight: 294.42
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: CNCCSc1nc2ccccc2cc1-c1ccccc1.Cl
Standard InChI: InChI=1S/C18H18N2S.ClH/c1-19-11-12-21-18-16(14-7-3-2-4-8-14)13-15-9-5-6-10-17(15)20-18;/h2-10,13,19H,11-12H2,1H3;1H
Standard InChI Key: IJPHQUUJCRLHOH-UHFFFAOYSA-N
Molfile:
RDKit 2D
22 23 0 0 0 0 0 0 0 0999 V2000
5.0929 1.1291 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
-2.6111 0.7486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2964 1.4973 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-2.6111 -0.7486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2964 -1.4973 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 0.7486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 -0.7486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.9086 -1.5029 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.9091 1.5019 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
-5.2025 5.2568 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.2964 1.4973 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2964 -1.4973 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.9067 3.0027 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.9097 -3.0028 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.2071 -0.7519 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.2049 3.7560 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.2404 5.8591 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5929 0.7486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5929 -0.7486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.5067 -1.5010 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.2093 -3.7519 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.5078 -3.0010 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 3 2 0
2 4 1 0
4 5 2 0
3 6 1 0
5 7 1 0
6 7 1 0
4 8 1 0
2 9 1 0
6 11 2 0
7 12 2 0
9 13 1 0
8 14 1 0
8 15 2 0
10 16 1 0
13 16 1 0
10 17 1 0
11 18 1 0
12 19 1 0
18 19 2 0
15 20 1 0
14 21 2 0
20 22 2 0
21 22 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 294.42 | Molecular Weight (Monoisotopic): 294.1191 | AlogP: 4.21 | #Rotatable Bonds: 5 |
Polar Surface Area: 24.92 | Molecular Species: BASE | HBA: 3 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 2 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 9.41 | CX LogP: 4.38 | CX LogD: 2.38 |
Aromatic Rings: 3 | Heavy Atoms: 21 | QED Weighted: 0.56 | Np Likeness Score: -0.76 |
References
1. Blackburn TP, Cox B, Guildford AJ, Le Count DJ, Middlemiss DN, Pearce RJ, Thornber CW.. (1987) Synthesis and 5-hydroxytryptamine antagonist activity of 2-[[2-(dimethylamino)ethyl]thio]-3-phenylquinoline and its analogues., 30 (12): [PMID:3681895] [10.1021/jm00395a013] |